Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A B-lymphoblastic leukemia/lymphoma that has a gene expression profile similar to that of B-ALL with t(9;22)(q34.1;q11.2) BCR-ABL1, but lacks that gene fusion.
No clinical trials have been registered for B-lymphoblastic leukemia/lymphoma, BCR-ABL1–like.
8 publications have been identified in PubMed for B-lymphoblastic leukemia/lymphoma, BCR-ABL1–like. Research spans Case Report / Case Series (50%), Other (13%), and Review / Meta-Analysis (13%).
Chahine Z (2025). [PMID: 39842907](https://pubmed.ncbi.nlm.nih.gov/39842907/). *BMJ Case Rep*. [Case Report / Case Series]
Han L (2025). [PMID: 39754542](https://pubmed.ncbi.nlm.nih.gov/39754542/). *Pediatr Blood Cancer*. [Case Report / Case Series]
Raharjo B (2025). [PMID: 40757104](https://pubmed.ncbi.nlm.nih.gov/40757104/). *J Med Life*. [Case Report / Case Series]
Yu X (2024). [PMID: 39056282](https://pubmed.ncbi.nlm.nih.gov/39056282/). *Elife*. [Basic Science / Preclinical]
Alshomrani A (2024). [PMID: 39585574](https://pubmed.ncbi.nlm.nih.gov/39585574/). *J Hematop*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 1:11 PM UTC
Common questions about B-lymphoblastic leukemia/lymphoma, BCR-ABL1–like
Mroz P (2024). [PMID: 39461758](https://pubmed.ncbi.nlm.nih.gov/39461758/). *J Mol Diagn*. [Other]
Yan YC (2024). [PMID: 39231779](https://pubmed.ncbi.nlm.nih.gov/39231779/). *Zhonghua Xue Ye Xue Za Zhi*. [Review / Meta-Analysis]